Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome.
Utku IltarFadime Nurcan AlhanEce VuralÜnal AtaşHasan SozelÖmer DoğanAhmet BoduroğluOrhan Kemal YücelOzan SalimLevent ÜndarPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Because it is a rare condition, clinicians should not overlook AZA as a possible cause of arthritis exacerbations when arthritis of unknown etiology develops in patients treated with AZA.